SPRY insider transactions
ARS Pharmaceuticals Inc. (SPRY) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for SPRY
- SEC Form 3 filed by new insider Casale Donn3 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Scott Kathleen D.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Karas Eric4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Legal Officer Fitzpatrick Alexander A4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Dorsey Brian4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Business Officer Chakma Justin4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by CHIEF MEDICAL OFFICER Tanimoto Sarina4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Lowenthal Richard E4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Operating Officer Dorsey Brian exercised 21,828 shares at a strike of $0.64 and sold $190,050 worth of shares (21,828 units at $8.71) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin exercised 30,000 shares at a strike of $0.84 and sold $1,476,147 worth of shares (166,380 units at $8.87), closing all direct ownership in the company (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shah Pratik gifted 350,000 shares (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $724,345 worth of shares (50,000 units at $14.49) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Financial Officer Scott Kathleen D. exercised 12,500 shares at a strike of $1.50 and sold $187,500 worth of shares (12,500 units at $15.00) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $703,755 worth of shares (50,000 units at $14.08) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 15,000 shares at a strike of $1.50 and sold $254,860 worth of shares (15,000 units at $16.99) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Large owner Flynn James E sold $13,663,151 worth of shares (740,149 units at $18.46) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Dadoo Rajeev4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Thompson Peter A.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Shah Pratik4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Kelly Michael4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Islam Saqib4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Saunders Brent L4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Schneider Phillip M4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Director Shawver Laura4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 15,000 shares at a strike of $1.50 and sold $240,000 worth of shares (15,000 units at $16.00) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Financial Officer Scott Kathleen D. exercised 50,000 shares at a strike of $1.50 and sold $705,165 worth of shares (50,000 units at $14.10) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Saunders Brent L sold $1,710,024 worth of shares (120,000 units at $14.25) and exercised 120,000 shares at a strike of $1.01 (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Legal Officer Fitzpatrick Alexander A exercised 100,000 shares at a strike of $5.58 and sold $1,451,513 worth of shares (102,969 units at $14.10), decreasing direct ownership by 3% to 89,613 units (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,002 shares at a strike of $4.85 and sold $615,075 worth of shares (50,002 units at $12.30) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 10,000 shares at a strike of $1.50 and sold $140,000 worth of shares (10,000 units at $14.00) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,000 shares at a strike of $4.85 and sold $560,446 worth of shares (50,000 units at $11.21) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,000 shares at a strike of $4.54 and sold $615,565 worth of shares (50,000 units at $12.31) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 50,000 shares at a strike of $3.15 and sold $555,065 worth of shares (50,000 units at $11.10) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by CHIEF MEDICAL OFFICER Tanimoto Sarina4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Business Officer Chakma Justin4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Karas Eric4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Legal Officer Fitzpatrick Alexander A4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Operating Officer Dorsey Brian4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by PRESIDENT AND CEO Lowenthal Richard E4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Scott Kathleen D.4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $1,167,100 worth of shares (100,000 units at $11.67) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $1,167,100 worth of shares (100,000 units at $11.67) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin exercised 144,605 shares at a strike of $0.95 and sold $1,768,093 worth of shares (144,605 units at $12.23) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Operating Officer Dorsey Brian exercised 40,000 shares at a strike of $0.64 and sold $493,858 worth of shares (40,000 units at $12.35) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin exercised 50,000 shares at a strike of $0.84 and sold $657,625 worth of shares (50,000 units at $13.15) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $1,316,420 worth of shares (100,000 units at $13.16) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $1,316,420 worth of shares (100,000 units at $13.16) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina exercised 37,541 shares at a strike of $5.86, increasing direct ownership by 0.75% to 3,433,512 units (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E exercised 37,541 shares at a strike of $5.86, increasing direct ownership by 0.28% to 4,327,189 units (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin exercised 144,640 shares at a strike of $0.84 and sold $2,041,200 worth of shares (144,640 units at $14.11) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin exercised 90,000 shares at a strike of $0.84 and sold $1,208,619 worth of shares (90,000 units at $13.43) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Director Shawver Laura exercised 200,000 shares at a strike of $2.00 and sold $2,688,751 worth of shares (200,000 units at $13.44) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Commercial Officer Karas Eric exercised 10,000 shares at a strike of $1.50 and sold $140,423 worth of shares (10,000 units at $14.04) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Chief Business Officer Chakma Justin sold $1,411,742 worth of shares (100,000 units at $14.12), decreasing direct ownership by 42% to 136,380 units (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $1,394,960 worth of shares (100,000 units at $13.95) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $1,394,960 worth of shares (100,000 units at $13.95) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- PRESIDENT AND CEO Lowenthal Richard E sold $1,684,642 worth of shares (100,000 units at $16.85) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- CHIEF MEDICAL OFFICER Tanimoto Sarina sold $1,684,642 worth of shares (100,000 units at $16.85) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)
- Large owner Flynn James E sold $10,143,706 worth of shares (563,270 units at $18.01) (SEC Form 4)4 - ARS Pharmaceuticals, Inc. (0001671858) (Issuer)